ACBP: Scientists Identify Key Protein Driving Bone Metastasis, Pointing to New Therapeutic Strategies
/0 Comments/in CRISPR, Preclinical Research/by MaxTargeting the Undruggable: SCORT–Cas13d Nanotherapy Against Metastatic Prostate Cancer
/0 Comments/in CRISPR, Preclinical Research/by MaxOrally Delivered CRISPR Therapy, Groundbreaking Evolution
/0 Comments/in CRISPR, Not PCa related, Preclinical Research/by MaxAdvancements in Delivery: Gene Therapy Could Help Prostate Cancer Treatment
/0 Comments/in CRISPR, Delivery, Preclinical Research/by MaxCRISPR Strikes Again: Fat Cells Starve Tumors,A Revolutionary Approach to Cancer Treatment
/0 Comments/in CRISPR, Preclinical Research/by MaxTargeting LIG1 with PARP Inhibitors: E New Target Identified Using CRISPR
/0 Comments/in CRISPR, PARPi, Preclinical Research/by MaxCRISPR Gene Editing Silences Cancer-Causing Mutations
/0 Comments/in CRISPR, Not PCa related, Preclinical Research/by MaxHijacking the Brakes: Scientists Uncover Prostate Cancer’s Growth Secret
/0 Comments/in CRISPR, Preclinical Research/by MaxA New Dawn for Disease Treatment: Combining mRNA and RNAi Therapies
/0 Comments/in CRISPR, Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy castration-resistant prostate cancer CDK12 clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology olaparib oncolytic virus personalized medicine prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 23/2025 June 8, 2025
- Protein Design Leaps Forward Thanks to AI June 5, 2025
- Phase 1 Trial of XL309: USP1 Inhibitor Targeting DNA Repair in Solid Tumors June 5, 2025
- UPDATE About ACE-232: Phase 1 Trial of a Novel CYP11A1 Inhibitor for mCRPC June 5, 2025